The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 13, 2019
Filed:
Oct. 18, 2018
Applicant:
Dart Neuroscience (Cayman) Ltd., Grand Cayman, KY;
Inventors:
Bryan Branstetter, Carlsbad, CA (US);
James Breitenbucher, Escondido, CA (US);
Brian Dyck, San Diego, CA (US);
Laurent Gomez, San Diego, CA (US);
Andrew Richard Hudson, San Diego, CA (US);
Tami Jo Marrone, Carlsbad, CA (US);
Marco Peters, San Diego, CA (US);
Troy Vickers, San Diego, CA (US);
Michael I. Weinhouse, Escondido, CA (US);
Assignee:
Dart Neuroscience (Cayman) Ltd., Grand Cayman, KY;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 495/14 (2006.01); C07D 495/22 (2006.01); C07D 471/14 (2006.01); C07D 471/22 (2006.01); C07D 487/14 (2006.01); C07D 487/22 (2006.01); C07D 491/22 (2006.01); A61K 31/519 (2006.01); C07D 498/08 (2006.01); C07D 491/147 (2006.01); C07D 491/107 (2006.01); C07D 519/00 (2006.01); C07D 495/12 (2006.01); A61K 31/5377 (2006.01); A61K 31/541 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); A61K 31/553 (2006.01); A61K 31/5386 (2006.01); A61P 25/00 (2006.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/5386 (2013.01); A61K 31/541 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); A61K 31/553 (2013.01); A61P 9/00 (2018.01); A61P 25/00 (2018.01); C07D 471/14 (2013.01); C07D 487/14 (2013.01); C07D 491/107 (2013.01); C07D 491/147 (2013.01); C07D 491/22 (2013.01); C07D 495/12 (2013.01); C07D 495/14 (2013.01); C07D 495/22 (2013.01); C07D 498/08 (2013.01); C07D 519/00 (2013.01);
Abstract
Described herein are compounds of Formula I and Formula II, methods of their synthesis, compositions comprising the compounds, and use of the compounds and compositions in treating numerous diseases and disorders, including cognitive deficits associated with CNS diseases and disorders.